• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS23
Device Problems Perivalvular Leak (1457); Device Dislodged or Dislocated (2923)
Patient Problems Aortic Insufficiency (1715); Heart Failure (2206)
Event Date 12/09/2016
Event Type  Injury  
Event Description
The manufacturer was informed on this event through the recent publication 'acute dislocation of a perceval valve treated with tavi valve-in-valve: a literature review and case report' by julieta d morales-portano et al.A (b)(6)-year-old male with a history of hypertension, presented with severe dyspnea (nyha-iii); severe aortic stenosis was revealed by transthoracic echocardiography (tte); surgical procedure with a perceval valve size m (pvs23) was made without any complications (mean gradient 12 mmhg.The patient was transferred to the intensive care unit, but twenty-four hours after the procedure, the patient presented acute heart failure.The tee revealed a severe paravalvular leak, then fluoroscopy confirmed the dislocated and dysfunctional perceval valve.An emergency transcatheter aortic valve-in-valve (tavi-viv) procedure with a corevalve 29 mm was performed to correct the dislocated valve.The clinical status of the patient improved rapidly, and the patient was discharged without any complications one week after the procedure.
 
Event Description
The implant of the perceval was on (b)(6) 2016, and the date of tavi was (b)(6) 2016.The remainder of the information previously submitted remains unchanged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, british columbia
MDR Report Key9211727
MDR Text Key174598153
Report Number1718850-2019-01129
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup,Followup
Report Date 09/24/2019,02/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2020
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date09/24/2019
Device Age7 MO
Event Location Hospital
Date Report to Manufacturer09/24/2019
Date Manufacturer Received09/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-